HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shikonin suppresses the migratory ability of hepatocellular carcinoma cells.

Abstract
Shikonin is a traditional Oriental medical herb extracted from Lithospermum erythrorhizon. Many studies have shown that shikonin possesses anticancer ability against many different cancers, including hepatocellular carcinoma (HCC). Recently, tumor metastasis has been become an important clinical obstacle. However, the effect of shikonin on metastasis by HCC is unknown. The 50% inhibitory concentration (IC50) of shikonin on HCC cells was determined by an MTT assay and the xCELLigence biosensor system. The migratory ability of HCC cells was detected by a transwell migration assay and the xCELLigence biosensor system. Matrix metalloproteinase-2 and -9 (MMP-2 and -9) expression levels were determined by Western blotting, and the activities of MMP-2 and -9 were determined by gelatin zymography. We found that IC50 values of HepJ5 and Mahlavu cells to shikonin treatment were around 2 μM. Exposure to a low dose of shikonin (0-0.4 μM) did not influence the survival of HCC cells. Interestingly, exposure to a low dose of shikonin inhibited the migratory ability on HepJ5 and Mahlavu cells. To further dissect the mechanism, we found that treatment with a low dose of shikonin reduced the activities and expression levels of MMP-2 and -9, which were correlated with the decreased cell migratory ability of HCC cells. In addition, we found a decrease of vimnetin expression, but no influence on the expression levels of N-cadherin, TWIST, or GRP78. In mechanism dissecting, we found that shikonin treatment may suppress the phosphorylation of AKT and then reduce the NF-κB (NF = nuclear factor) levels, but has no influence on the levels of c-Fos and c-Jun. Furthermore, we also found that shikonin may also reduce the phosphorylation of IκB. We concluded that a low dose of shikonin can suppress the migratory ability of HCC cells through downregulation of expression levels of vimentin and MMP-2 and -9. Our findings suggest that shikonin may be a new compound to prevent the migration of HCC cells.
AuthorsPo-Li Wei, Chao-Chiang Tu, Ching-Hsein Chen, Yuan-Soon Ho, Chun-Te Wu, Hou-Yu Su, Wei-Yu Chen, Jun-Jen Liu, Yu-Jia Chang
JournalJournal of agricultural and food chemistry (J Agric Food Chem) Vol. 61 Issue 34 Pg. 8191-7 (Aug 28 2013) ISSN: 1520-5118 [Electronic] United States
PMID23899086 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Drugs, Chinese Herbal
  • Endoplasmic Reticulum Chaperone BiP
  • HSPA5 protein, human
  • Naphthoquinones
  • shikonin
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
Topics
  • Carcinoma, Hepatocellular (enzymology, genetics, pathology, physiopathology)
  • Cell Line, Tumor
  • Cell Movement (drug effects)
  • Drugs, Chinese Herbal (pharmacology)
  • Endoplasmic Reticulum Chaperone BiP
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Lithospermum (chemistry)
  • Liver Neoplasms (enzymology, genetics, pathology, physiopathology)
  • Matrix Metalloproteinase 2 (genetics, metabolism)
  • Matrix Metalloproteinase 9 (genetics, metabolism)
  • Naphthoquinones (pharmacology)
  • Neoplasm Metastasis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: